Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Opdivo plus Yervoy moves closer to EU approval for dMMR/MSI-H colorectal cancer

pharmatimesMay 26, 2021

Tag: BMS , Opdivo , Yervoy , dMMR , MSI-H

PharmaSources Customer Service